Caspase Inhibitors as a Supplement in Immune Activation Therapies to Achieve Eradication of HIV in Its Latent Reservoirs

Annals of the New York Academy of Sciences

Volumn 1010, Issue , 2003, Pages 209-212

  Scheller, Carsten ^a,b   Sopper, Sieghart ^a   Koutsilieri, Eleni ^a   Ludwig, Stephan ^a   Ter Meulen, Volker ^a   Jassoy, Christian ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; Caspase inhibitors; Eradication; HIV; Reactivation; TNF R1

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; CYTOKINE; FAS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; SIDE EFFECT; SIGNAL TRANSDUCTION; VIRUS REACTIVATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 84931266727     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1299.036     Document Type: Conference Paper

References (5)

1. KULKOSKY, J. & R.J. POMERANTZ. 2002. Approaching eradication of highly active anti-retroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy. Clin. Infect. Dis. 35: 1520-1526.
2. FOLKS, T.M., K.A. CLOUSE, J. JUSTEMENT, et al. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86: 2365-2368.
3. BAUD, V. & M. KARIN. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11: 372-377.
4. SCHELLER, C., S. SOPPER, P. CHEN, et al. 2002. Caspase inhibition activates HIV in latently infected cells. Role of tumor necrosis factor receptor 1 and CD95. J. Biol. Chem. 277: 15459-15464.
5. SCHELLER, C., S. SOPPER, C. EHRHARDT, et al. 2002. Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes. Eur. J. Immunol. 32: 2471-2480.